Human herpesvirus-6 variant A encephalomyelitis.
Pot
C
C
Department of Neurosciences, Division of Neurology, Geneva University Hospital, Micheli-du-Crest 24, 1211 Geneva 14, Switzerland.
Burkhard
P R
PR
Villard
J
J
Perrin
L
L
Kaiser
L
L
Landis
T
T
Lalive
P H
PH
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D002490:Central Nervous System / Q000473:pathology / Q000503:physiopathology / Q000821:virology*; D002531:Cerebellum / Q000473:pathology / Q000503:physiopathology / Q000821:virology; D018450:Disease Progression; D004679:Encephalomyelitis / Q000188:drug therapy / Q000473:pathology / Q000821:virology*; D005260:Female; D005334:Fever / Q000209:etiology; D020233:Gait Disorders, Neurologic / Q000473:pathology / Q000503:physiopathology / Q000821:virology; D015774:Ganciclovir / Q000627:therapeutic use; D015654:Herpesvirus 6, Human / Q000145:classification / Q000302:isolation & purification*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009434:Neural Pathways / Q000473:pathology / Q000503:physiopathology / Q000821:virology; D019349:Roseolovirus Infections / Q000150:complications* / Q000473:pathology; D020886:Somatosensory Disorders / Q000473:pathology / Q000503:physiopathology / Q000821:virology; D013116:Spinal Cord / Q000473:pathology / Q000503:physiopathology / Q000821:virology; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D015774:Ganciclovir; D008775:Methylprednisolone